Back to mobile site

Reviva Pharmaceuticals Holdings, Inc. (RVPH) Tops Q2 EPS by 1c

August 14, 2025 5:48 PM EDT

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q2 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK